Abstract:Background: Familial progressive hyper- and hypopigmentation (FPHH, MIM 145250) is a rare hereditary skin disorder that is predominantly characterized by progressive, diffuse, partly blotchy hyperpigmented lesions intermingled with scattered hypopigmented spots, lentigines and sometimes Cafe-au-lait spots (CALs). Heterozygous mutations of the KIT ligand ( KITLG , MIM 184745) gene are responsible for FPHH. To date, only eight KITLG mutations have been reported to be associated with FPHH, and no clear genotype-phenotype correlations have been established. This study aimed to identify the causative mutations in the KITLG gene in two Chinese FPHH patients. Methods: Direct sequencing of the coding regions of KITLG was performed. Pathogenicity prediction was performed using bioinformatics tools, including SIFT, Polyphen2, and SWISS-MODEL, and the results were further evaluated according to the 2015 American College of Medical Genetics and Genomics (ACMG) guidelines. Results: The novel mutation c.104A>T (p.Asn35Ile) and the recurrent mutation c.101C>T (p.Thr34Ile) in KITLG were identified. As shown using SIFT and Polyphen-2 software, both mutations identified in this study were predicted to be detrimental variations. Three-dimensional protein structure modeling indicated that the mutant KITLG proteins might affect the affinity of KITLG for its receptor, c-KIT. According to the 2015 ACMG guidelines, the novel mutation c.104A>T was ‘likely pathogenic’. Conclusions: To date, most of the identified KITLG mutations have been clustered within the conserved VTNNV motif (amino acids 33-37) in exon 2. The known mutations are only involved in 33V, 34T, 36N, and 37V but not 35N. We have now identified a novel mutation in KITLG , c.104A>T, that was first reported in FPHH within the conserved 35N motif. These results strengthen our understanding of FPHH and expand the mutational spectrum of the KITLG gene.

NAPG mutation in family members with hereditary hemorrhagic telangiectasia in China

The ENG/VEGFα Pathway Is Likely Affected by a Nonsense Variant of Endoglin (ENG)/CD105, Causing Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) in a Chinese Family

Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy.

ATL3 gene mutation in a Chinese family with hereditary sensory neuropathy type 1F

Genetic diagnosis of Hailey-Hailey disease in two Chinese families: novel mutations in the ATP2C1 gene.

[Hereditary Hemorrhagic Telangiectasia Resulted from a Nonsense Mutation Arg479 Stop in the ALK-1 Gene].

Functional characterization of variants found in Japanese patients with hereditary hemorrhagic telangiectasia

Localization of the Pathogenic Gene of Hereditary Hemorrhagic Talangiectasia in a Chinese Family of Han Nationality

[Mutation Analysis of the Pathogenic Gene in a Chinese Family with Hereditary Hemochromatosis].

Genetic Variants and Clinical Phenotypes in Korean Patients With Hereditary Hemorrhagic Telangiectasia

Mutation Analysis of ALK-1 Gene in a Chinese Family with Hereditary Hemorrhagic Teiangiectasis Type II and Its Minimally Invasive Treatment in Clinic

Hereditary Hemorrhagic Telangiectasia with Recurrent Epistaxis, Telangiectasia, Hepatic Arteriovenous Malformation, and a Poorly Developed Middle Cerebral Artery in a Patient with a Novel Mutation in the ACVRL1 Gene

Clinical features and screening of ACVRL1 gene in Ⅱ hereditary hemorrhagic telangiectasia

Mutation Analysis of ATP2C1 Gene in a Chinese Pedigree with Infancy-Onset Hailey-Harley Disease (HHD)

Pro-angiogenic changes of T-helper lymphocytes in hereditary hemorrhagic telangiectasia

Identification of a Novel Mutation in the KITLG Gene in a Chinese Family with Familial Progressive Hyper- and Hypopigmentation

[Analysis of clinical phenotypes and genetic variations in a Chinese family affected with craniofacial and skeletal deformities]

Clinical and Genetic Analysis of the Von Hippel-Lindau (VHL) Gene in Two Chinese Pedigrees with VHL Syndrome

Genetic characterization of Chinese hereditary non-polyposis colorectal cancer by DHPLC and multiplex PCR.

Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT)

Autologous Correction in Patient Induced Pluripotent Stem Cell-Endothelial Cells to Identify a Novel Pathogenic Mutation of Hereditary Hemorrhagic Telangiectasia